Abstract
Mesenchymal stem cells (MSCs) possess unique properties such as immunomodulation, paracrine actions, multilineage differentiation, and self-renewal. Therefore, MSC-based cell therapy is an innovative approach to treating various degenerative illnesses, including cardiovascular diseases. However, several challenges, including low transplant survival rates, low migration to the ischemic myocardium, and poor tissue retention, restrict the application of MSCs in clinical settings. These undesirable cell therapy outcomes mainly originated due to the overproduction of reactive oxygen species (ROS) in the injured heart. MSCs' stress-coping capacity can be enhanced by preconditioning them under conditions similar to the microenvironment of wounded tissues. Hydrogen peroxide (H2O2) is a ROS that has been shown to activate protective cellular mechanisms such as survival, proliferation, migration, paracrine effects, and differentiation at sublethal doses. These processes are induced via phosphatidylinositol 3-kinase/protein kinase B, p38 mitogen-activated protein kinases, c-Jun N-terminal kinase, Janus kinase/signal transducer and activator of the transcription, Notch1, and Wnt signaling pathways. H2O2 preconditioning could lead to many clinical benefits, including ischemic injury reduction, enhanced survival of cellular transplants, and tissue regeneration. In this review, we present an overview of stem cell preconditioning methods and the biological functions activated by H2O2 preconditioning. Furthermore, this review explores the molecular mechanisms underlying the protective cellular functions stimulated under H2O2 preconditioning.
Keywords: Stem cells, Redox signaling, Hydrogen peroxide, Preconditioning, Heart regeneration, Redox sensitive transcription factors
Core Tip: Hydrogen peroxide (H2O2) preconditioning is reported to increase protective mechanisms in mesenchymal stem cells and enhance their ability to regenerate in damaged hearts. However, its molecular mechanism remains under-explored. This review highlights the studies on the protective biological functions and regulatory mechanisms associated with H2O2 preconditioning in heart regeneration. Moreover, the role of the H2O2-activated redox-sensitive transcription factors and their associated pathways in cell survival, proliferation, migration, paracrine effect, and cardiac differentiation is discussed. The molecular insights provided in this review will possibly help in the development of cardiovascular regenerative therapy.
INTRODUCTION
Redox imbalance, which is caused by a compromised antioxidant system or an overabundance of reactive oxygen species (ROS), is a major factor in cardiovascular disorders such as myocardial infarction (MI), ischemia-reperfusion damage, end-stage heart failure, and cardiomyopathy[1]. Heart transplantation remains the most effective treatment for heart failure because existing treatments have limited efficacy and cannot restore the heart's normal functions. However, this procedure is limited due to donor organ unavailability, immunological rejection, long-term complications, and higher expenses[2].
Mesenchymal stem cell (MSC) therapy has shown promise as an alternative method for restoring heart function in individuals with cardiovascular disorders[3]. MSCs are adult stem cells that can self-renew and differentiate into several lineages. These cells are found in bone marrow, adipose tissue, umbilical cord, and several other tissues and organs[4]. Studies have demonstrated that transplanted MSCs can differentiate into vascular cells and cardiomyocytes in heart models[5]. Since stem cell self-renewal and differentiation are dependent upon the redox balance of the tissue, stem cells cannot survive in inflamed tissue for long periods due to the hostile microenvironment[6].
Preconditioning is a technique that refers to the brief exposure of cells to mild stressors to get them ready for the harsh environment that they may experience in the diseased tissue[7]. Numerous preconditioning methods, such as chemical agents, hypoxia, gene modification, pharmacological agents, and physical factors have been investigated to increase the overall effectiveness of MSC transplantation[8]. It has been reported that pretreatment of MSCs with a controlled stressor can improve their proliferative, secretory, migratory, and differentiated properties[9]. Numerous studies have demonstrated that hydrogen peroxide (H2O2) acts as a signaling molecule at low concentrations, enabling cells to establish a cytoprotective response against stress[10,11]. In this review, we discuss MSC preconditioning methods with an emphasis on the stem cell functions modulated by H2O2 preconditioning. We also provide an overview of the molecular mechanisms underlying the protective cellular mechanism stimulated by H2O2 preconditioning.
MSCS IN HEART DISEASES
MSCs are increasingly being used in regenerative medicine to develop cell treatments. MSCs have demonstrated remarkable therapeutic results in several preclinical disease models, including cardiac diseases[12]. It has been demonstrated that MSCs, their genetic modifications, conditioned medium, or extracellular vesicles (EVs), promote regeneration after cardiac tissue injury[4]. Moreover, various combinations of cardiac transcription factors (TFs) such as GATA binding protein 4 (GATA-4), Mef2c, and NK2 homeobox 5 (Nkx2.5) play important roles in cardiac differentiation and heart regeneration[13]. Paracrine signals including insulin-like growth factor (IGF), hepatic growth factor, and vascular endothelial growth factor (VEGF) are reported to stimulate transdifferentiation of stem cells into cardiomyocytes and endothelial cells[14]. Studies reported that anti-inflammatory, anti-fibrotic, anti-apoptotic, and angiogenic properties are mediated through MSC-derived exosomal microRNAs (miRNAs)[4]. However, the long-term clinical translation of MSC therapy is hindered by the poor survival of MSCs in damaged hearts. Therefore, it is crucial to discover new methods to improve the therapeutic efficiency of MSCs. There is growing evidence that specific preconditioning methods can prime MSCs for cell therapy in vitro. Moreover, preconditioning techniques can maximize the reparative and regenerative capacity of MSCs by improving their paracrine, engraftment, and survival properties[8]. Presently, several in vitro preconditioning techniques have been used to increase MSCs' ability to regenerate in damaged hearts.
CELL PRECONDITIONING METHODS
Hypoxic preconditioning
Hypoxic preconditioning is a method where cells are exposed to moderate hypoxia for a shorter period of time which results in increased resistance to severe ischemic conditions[15]. Preconditioning techniques regulate a range of biological processes by either activating or suppressing chemical signals and signal transduction pathways[9]. Hypoxic preconditioned MSCs (HP-MSCs) release a wide range of substances with anti-apoptotic, pro-angiogenic, trophic, immunomodulatory, or immunosuppressive properties[16]. A number of studies have demonstrated the therapeutic potential of HP-MSCs in heart regeneration[9,17,18]. It has been reported that HP-MSCs following transplantation provide cardioprotective benefits in terms of increased neovascularization and reduced fibrosis[19]. According to research, controlled hypoxia is reported to improve cardiovascular health and oxygen supply by increasing blood vessel density, myocardial contractility, and erythropoietin (EPO) production[20]. Moreover, hypoxia is reported to enhance EVs loaded with miRNAs such as miR-210 to heal MI[21].
Preconditioning with mechanical/electrical /magnetic stimuli
A number of physical preconditioning methods such as shear stress, stretch, compression, and electrical or magnetic fields have shown promising results in the field of regenerative medicine[22]. These methods are reported to enhance MSCs’ ability to regenerate damaged tissues[7,23]. It has been reported that shear stress improves MSC alignment and stimulates the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt)/endothelial nitric oxide (NO) synthase pathway, which in turn promotes angiogenesis and healing of ischemic cardiac tissues[24]. Cyclic stretch is reported to enhance survival and cardiac differentiation of MSCs through the mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinases (ERK) and YAP/TAZ pathways[25,26]. Electrical stimulation has been shown to increase calcium signaling and the Wnt/β-catenin pathway, which results in cardiac differentiation of MSCs[27]. MSCs preconditioned with magnetic fields are reported to boost the repair mechanism of the injured heart via increased migration and homing[28].
Preconditioning with biological and pharmacological agents
Biological and pharmacological preconditioning agents have been shown to enhance MSC survival, proliferation, differentiation, and paracrine activities in the injured myocardium[8]. MSCs enhance their survival and integration properties in infarcted heart tissue once preconditioned with growth factors and cytokines such as fibroblast growth factor (FGF)-2, VEGF, and stromal cell-derived factor-1 (SDF-1). These paracrine factors have been shown to activate pro-survival and anti-apoptotic pathways PI3K/Akt and ERK1/2 in preconditioned MSCs[29]. C-X-C motif chemokine receptor 4 (CXCR4)/stromal cell-derived factor-1 (SDF-1) signaling is reported to play an important role in MSC survival in the ischemic myocardium which results in infarct repair and enhanced vascular density[30]. Research indicates that EPO treated MSCs reduce apoptosis and fibrosis, and enhance survival through the PI3K/Akt pathway in MI animal models[31]. It has been reported that tumor necrosis factor-alpha preconditioned MSCs release anti-inflammatory cytokines, which in turn enhance the immunomodulatory properties of MSCs[32]. Additionally, MSCs preconditioned with growth differentiation factor 15 are reported to show anti-inflammatory properties in an MI model via the AMP-activated protein kinase (AMPK) pathway[33]. These preconditioning approaches primarily provide cytoprotection. Yet, we should examine preconditioning strategies which more accurately replicate the ischemic state of the infarcted heart while enabling positive tissue regeneration and differentiation, besides increasing cell resistance to stress. ROS, proinflammatory cytokines, and other stress-related molecules are present in high concentrations in the infarcted myocardial environment. However, H2O2 is a well-defined ROS, which at sublethal doses can act as a second messenger and also a mediator of oxidative stress. Recently, it has been shown that preconditioning MSCs with low doses of H2O2 for shorter periods makes them more resilient to oxidative stress. These H2O2 preconditioned MSCs[34-38] have been reported to activate various protective mechanisms to improve therapeutic potential of stem cells in cell therapy procedures[39-41]. It has been reported that H2O2 preconditioning enhance tissue engraftment and accelerate wound healing in mice via the activation of the SDF-1/CXCR4 and PI3K/Akt/mammalian target of rapamycin pathways and inhibition of glycogen synthase kinase-3β in MSCs[35]. Another study demonstrated that H2O2 pretreated human umbilical cord vein MSCs repaired ovary injured in mice, presumably by increasing the migration and survival of the stem cell[36]. Recent research provides shreds of evidence that the paracrine factors released from H2O2-preconditioned human adipose-derived stem cells efficiently reduce ultraviolet (UV) B-induced oxidative stress by a higher nuclear factor erythroid 2-related factor 2 (Nrf2) antioxidant system[37]. Mahmoudi et al[39] in 2020 reported that optimized concentration of H2O2 can enhance therapeutic potential of MSCs in idiopathic pulmonary fibrosis. A study carried out by Boopathy et al[42] has demonstrated cardiac differentiation of H2O2 preconditioned MSCs via Notch1 and Wnt11 signaling pathways. These studies provide evidence for the hypothesis that H2O2 preconditioning is a strategy for promoting tissue-regeneration, wound healing, cell survival, and differentiation. Hence, the mechanism of H2O2 preconditioning needs to be explored further.
POTENTIAL CELLULAR MECHANISMS STIMULATED BY H2O2 PRECONDITIONING IN MSCS
H2O2 preconditioned MSCs promote survival
For efficient utilization of MSCs in heart regeneration, their survival must be increased by triggering adaptive cellular responses. A number of research studies support the narration that H2O2 preconditioning induces cell survival in MSCs by upregulating various signaling pathways such as Janus kinase/signal transducer and activator of the transcription, Akt, Nrf1, Nrf2, p38 MAPK, PI3K/Akt, Notch1, and Wnt11[34,42-44]. In 2020, Garrido Pascual[45] reported that preconditioning with 0.25 mmol H2O2 for 1 hour regulates the effects of oxidative stress in transplanted MSCs by increasing the expression of the transcription factor Nrf2 and antioxidant enzymes catalase (CAT), superoxide dismutase (SOD), heme oxygenase-1 (HO-1), and glutathione peroxidase (GPx)-1. Moreover, these preconditioned MSCs are reported to increase cell survival by reducing the secretion of pro-inflammatory molecules cyclooxygenase-2 and interleukin (IL)-1β and by increasing adenosine triphosphate production. Sadidi et al[46] in 2009 have also reported increased survival and growth of preconditioned MSCs via the PI3K/Akt signaling pathway. According to the research by Nouri et al[34] in 2019, MSCs pretreated with 20 μM H2O2 for 12 hours exhibited enhanced cell survival in the ischemic heart via the hypoxia-inducible factor-1α (HIF-1α) and PI3K/Akt pathways.
H2O2 preconditioned MSCs promote proliferation
Adequate cell count is a key factor that boosts MSCs’ capability to repair and regenerate damaged tissues[47]. MSCs’ functional characteristics such as proliferation, adhesion, and migration are reported to be enhanced by H2O2 preconditioning[41]. In 2012, Zhang et al[48] reported that preconditioning of MSCs with a low concentration of H2O2 stimulates cell migration and proliferation via IL-6 secretion. Moreover, H2O2 treated cells have been shown to modulate the production of phase II antioxidant enzymes via the PI3K/Akt and p38 MAPK pathways, thus promoting proliferation[44]. Similar proliferation results of preconditioned stem cells have been reported in a in vitro study of 2019 by Castro et al[49], who stated that the cryopreserved H2O2 preconditioned stem cells show improved bioactivity against oxidative stress through increased adhesion and cell cycle progression, suggesting a greater ability for proliferation.
H2O2 preconditioned MSCs promote migration
Cell migration plays a key role in various physiological processes including tissue regeneration and repair. A number of studies[34] have reported that H2O2 preconditioning enhances MSCs’ migration to ischemic myocardium following transplantation[41,48-51]. According to Zhang et al[48]’s research, H2O2 treated MSCs increase IL-6 secretion, which is found to be necessary for endothelial cell migration and proliferation, thus contributing to the remodeling of post-myocardial damage in the MI model. It has been reported that MSCs preconditioned with a non-toxic dose of H2O2 enhance cell migration and survival via modulation of Bax/Bcl-2 ratio and pro-survival proteins Bcl-2[34]. Notably, the destabilization of redox-sensitive phosphatase Dusp6 is a crucial step required for heart regeneration. H2O2 is reported to destabilize Dusp6 and activate the MAPK/ERK pathway, thus controlling several cellular activities, including migration and proliferation[50]. Moreover, it has been reported that pretreatment of MSCs with cytokines and H2O2 regulates their adhesion to cardiac endothelium, thus improving cell migration[43].
H2O2 preconditioned MSCs enhance release of paracrine factors
Preconditioning enhances MSCs' therapeutic potential by stimulating the release of paracrine chemicals through a variety of signaling pathways. A study has been carried out by Pankajakshan et al[52] has shown the H2O2 preconditioned MSCs release key paracrine factors involved in heart regeneration, such as VEGF, FGF-2, IGF-1, and IL-6. These soluble factors support heart regeneration via angiogenesis, cell survival, and immunomodulation[52]. A possible method to boost MSC-mediated tissue regeneration was suggested by a study, where MSCs were preconditioned with H2O2. These preconditioned MSCs showed higher proliferation and decreased inflammation rate through paracrine effects[53]. Furthermore, the research conducted by Pendergrass et al[54] described that H2O2 preconditioned cardiac progenitor cells stimulate neoangiogenesis in the peri-infarct region of an ischemia-reperfusion injury model. Another investigation revealed that H2O2 preconditioned MSCs stimulate the production of IL-6, which in turn enhances neovascularization and decreases cardiac fibrosis[48]. Moreover, H2O2 preconditioned cardiac progenitor cells show reduced fibrosis and enhanced angiogenesis and vascular density via the PI3K-dependent pathway[54].
H2O2 preconditioned MSCs enhance cardiac differentiation
H2O2 has been shown to act as signaling molecules that affect several biological pathways. Recently, it has been demonstrated that the key cardiovascular pathways, Notch1 and Wnt11, are activated in H2O2 preconditioned MSCs[55]. Notch1 signaling activation is reported to improve MSC based therapies for cardiac repair and regeneration[56]. A study conducted by Boopathy et al[42] reported that H2O2 mediated oxidative stress activates Notch1 signaling, which promotes cardiogenic gene expression in bone marrow derived MSCs. Exogenous H2O2 at low concentrations shows higher expression of cardiogenic TFs, cytokines, and a number of stem cells derived beating cardiomyocytes[57]. It is well-documented that H2O2 preconditioning enhances various cell protective mechanisms, survival, proliferation, migration, paracrine effects, and differentiation, by activating intracellular signaling pathways (Figure 1 and Table 1)[34,41-45,48-50,54,58-61]. However, there is still a large gap that needs to be filled with a thorough investigation of the underlying mechanisms of H2O2 preconditioning in heart regeneration.
Figure 1.
Hydrogen peroxide preconditioned mesenchymal stem cells promote heart regeneration. Redox sensitive transcription factors activated by hydrogen peroxide preconditioning regulate various biological functions such as cell survival, proliferation, migration, paracrine effects, and differentiation. This leads to an improvement in the regeneration of the heart. AP-1: Activator protein-1; HIF-1α: Hypoxia-inducible factor-1α; H2O2: Hydrogen peroxide; MSCs: Mesenchymal stem cells; Nrf2: Nuclear factor erythroid 2-related factor 2.
Table 1.
Hydrogen peroxide preconditioning promote heart regeneration
|
Cells
|
Cellular mechanism(s)
|
Redox sensitive transcription factor(s)
|
Pathway(s)
|
Major findings
|
Ref.
|
| Adipose-derived stem cells (hASCs) | Survival | Nrf2 | - | Increased: Antioxidant response; reduced: Inflammation; bioenergetic adaptation; nuclear factor-kappa B modulation | Garrido Pascual[45] |
| Cardiomyocytes | Survival | Nrf2 | - | Increased: Mitochondrial membrane potential; reduced: Oxidative stress, apoptosis in cardiomyocytes | Dreger et al[58] |
| Cardiomyocytes | Proliferation and survival | Nrf1 and Nrf2 | P38 MAPK and phosphatidylinositol 3-kinase/Akt | Increased: Phase II enzymes and Bcl2; reduced: Oxidative stress, apoptosis, and caspase-3; resistance to oxidative stress in ischemia-reperfusion injury | Angeloni et al[44] |
| Zebrafish cardiomyocytes | Proliferation and survival | P53 | - | Increased: Proliferation and redox homeostasis; reduced: Reactive oxygen species levels and scar formation | Ye et al[59] |
| Human Wharton's jelly-derived MSCs | Proliferation, survival, and migration | Hypoxia-inducible factor-1α | Akt | Increased: Resistance to oxidative stress and cell viability; reduced: Apoptosis | Nouri et al[34] |
| Human MSCs | Survival | - | - | Increased: Adhesion | O'Leary[43] |
| Mice myocytes | Survival | Catalase | - | Regulate calcium handling and improve ventricular diastolic dysfunction; preserve sarcoplasmic reticulum calcium ATPase activity | Qin et al[60] |
| Wharton's Jelly-derived MSCs | Survival, migration, paracrine effect, and differentiation | - | - | Increased: Neovascularization and interleukin-6; reduced: Fibrosis | Zhang et al[48] |
| HASCs | Proliferation, paracrine effects, and migration | - | - | Increased: Insulin-like growth factor-1, PFKFB4, pyruvate dehydrogenase kinase isoenzyme 1, resistance to oxidative stress, glycolysis; reduced: Oxidative phosphorylation | Castro et al[49] |
| Human decidua basalis mesenchymal stem/stromal cells | Proliferation, migration, and survival | - | - | Increased: Colony formation, adhesion, migration, wound-healing, tube formation, and oxidative stress resilience | Khatlani et al[41] |
| Zebrafish heart lines | Migration, and differentiation | - | MAPK and extracellular signal-regulated kinases 1/2 | Increased: Duox and NADPH oxidase 2; reduced: Dusp6 | Han et al[50] |
| Cardiac progenitor cells | Paracrine effect, differentiation, survival | - | - | Increased: Angiogenesis, endothelial cell density, survival, and cardiac function post-I/R injury; reduced: Fibrosis, apoptosis | Pendergrass et al[54] |
| Mouse cardiac myocytes | Survival and paracrine effect | - | AMP-activated protein kinase and Akt | Increased: Myocyte contractility; selective activation of nitric oxide synthase isoforms | Sartoretto et al[61] |
| Bone marrow-derived MSCs | Differentiation | - | Notch1 | Increased: Flt1, vWF, PECAM1, NK2 homeobox 5, αMHC, Notch1, Wnt11, cardiac repair and regeneration | Boopathy et al[42] |
Akt: Protein kinase B; HASCs: Human adipose-derived stem cells; MAPK: Mitogen-activated protein kinase; MSCs: Mesenchymal stem cells; Nrf2: Nuclear factor erythroid 2-related factor 2.
Role of H2O2-activated redox sensitive TFs in heart regeneration
Mammalian cells continuously produce ROS as byproducts of electron transport activities. At physiological levels, ROS serves a crucial role in redox signaling through various post-translational modifications. However, increased ROS production causes molecular damage, a condition known as oxidative distress. Therefore, maintaining the redox balance is crucial for normal cell functioning[62]. H2O2, a ROS and an essential redox signaling agent, is produced by several metabolic activities in mammalian cells[63]. It is an intracellular messenger that regulates a number of physiological processes by reversible oxidation of the thiol side chain of cysteine residues of the effector proteins, thereby modulating the downstream gene expression and cell behaviors[57]. Heart development is regulated by a network of TFs such as Nkx2.5, GATA-4, Mef2c, and Tbx5[13]. Cardiac TFs might not be directly targeted by ROS, but their regulation can be controlled by redox sensitive TFs[57]. According to earlier research[64], oxidative stress caused by low-concentration H2O2 supplementation to culture media activates redox sensitive TFs, including Nrf2, activator protein-1 (AP-1), p53[65], and HIF-1α[34]. These TFs control the intracellular signaling pathways involved in the development/regeneration of the heart[58,59,66,67]. However, the precise role of redox sensitive TFs in heart repair is not fully understood yet. Therefore, it is now essential to uncover their molecular mechanism to target specific biological pathways to ensure improved survival, proliferation, and differentiation of cells in ischemic myocardium, thus increasing the outcome of cardiovascular regenerative therapy.
Nrf2
The basic leucine zipper transcription factor Nrf2 is encoded by the human NFE2 L2 gene. In normal conditions, Nrf2 resides in the cytoplasm because it assembles with kelch-like ECH-associated protein 1 (Keap1). Keap1 is the main negative regulator of Nrf2 that constantly ubiquitylates and degrades Nrf2. Deubiquitination, which is caused by the disruption of the Keap1-Cul3 E3 Ligase complex, releases and accumulates Nrf2 in the nucleus. In the nucleus, Nrf2 interacts with Maf proteins and binds to the antioxidant-response elements (ARE). This interaction promotes the transcription of Nrf2 target genes such as HO-1, GPx, CAT, and SOD. These enzymes are reported to promote cell viability, migration, and proliferation by balancing the redox status of cells[68].
Nrf2's complex transcriptional, translational, and post-translational network regulation allows it to coordinate adaptive responses to different types of stress. It has been proposed that Nrf2 acts as a mediator of protective responses since it is activated in response to moderate concentrations of various stressors and conditions[69]. In the process of tissue regeneration, stem and progenitor cell proliferation is reported to be promoted by Nrf2[70]. Moreover, Nrf2 regulates apoptosis through inhibition of pro-apoptotic and upregulation of anti-apoptotic proteins. In addition, Nrf2, directly or indirectly, controls the expression of cell cycle genes like cyclin D1[71] and c-Myc[72]. It has been documented in various studies that 10–500 μM H2O2 for 10 minutes to 6 hours can activate Nrf2 in a variety of cells[37,73,74]. In a study in 2022, Ishii et al[73] reported that H2O2-activated kinases liberate Nrf2 from caveolin-1, facilitating its nuclear translocation via p38/nSMase2/ceramide signaling. Furthermore, it has been demonstrated that the H2O2 activated Nrf2 enters the nucleus, attaches to AREs in target gene promoters, and upregulates the expression of various antioxidant enzymes, which guards cardiac cells from oxidative damage[58]. In 2022, a similar finding was reported by Yang et al[75] that Nrf2 induces the expression of HO-1 in the heart. This enzyme breaks down heme into biliverdin, carbon monoxide, and free iron, providing cytoprotective benefits against oxidative damage[75]. Moreover, it has been reported that Nrf2 activation promotes the pentose phosphate pathway and glucose metabolic reprogramming, which lessens cardiac dysfunction[76].
AP-1
The transcription factor AP-1 is produced by various dimeric combinations of Fos and Jun families. The synthesis of new Jun and Fos family proteins is triggered by ROS and is dependent on pre-existing TFs[77]. AP-1 is reported to control the signal transduction pathways that lead to cell growth and transformation[78]. Moreover, AP-1 activity is noticeably increased in the presence of antioxidants such as pyrrolidine dithiocarbamate and butylated hydroxyanisole[79]. In response to a variety of stimuli, such as growth hormones, cytokines, oxidative stress, and other environmental signals, AP-1 attaches to the TPA response element in target genes' promoter regions and regulates the transcription of stress responses, apoptosis, differentiation, and cell proliferation[80].
In 2013, a study conducted by Windak et al[81], reported that c-Jun and c-Fos play critical role in the induction of cardiac fetal genes. c-Jun has been shown to shield the heart against pathologic remodeling and maintain the correct arrangement of the cytoskeleton and sarcomeric structure in cardiomyocytes. Moreover, deletion of c-Jun in cardiomyocytes is linked to a higher incidence of cardiac apoptosis and fibrosis. ROS-dependent activation of c-Jun is reported to be controlled by the c-Jun N-terminal kinase (JNK)-dependent and MAPK family signaling pathway[81]. It has been reported that the coordinated activation of JNK, ERK, and p38 MAPKs increases the DNA binding and transactivation capacity of c-Jun in P19 cells[82]. According to the bioinformatics investigations, the cardiac transcription factor GATA-4 promoter region contains three putative binding sites for AP-1 that bind to activated c-Jun and promote the redox-dependent increase in GATA-4 transcription. This process possibly drives the differentiation of stem cells into cardiac cells during the process of embryonic development[83].
AP-1 production is stimulated by various stimuli such as UV light, ionizing radiation, or H2O2[84]. In 2006, Kikuta et al[85] reported that 100 μM H2O2 for 25 hours activates AP-1 by MAPKs, which phosphorylate AP-1 components and increase their transcriptional activity. In earlier studies, it was reported that H2O2 treatment increases AP-1 DNA binding, Jun nuclear kinase activity, and the levels of c-Fos and c-Jun mRNA[86]. AP-1 is reported to regulate the expression of certain antioxidant enzymes and proteins, as well as transforming growth factor-1 beta (TGF-1β)[87], cyclin D1[88], and many cytokines genes, which help in cell cycle progression. Moreover, AP-1 is reported to regulate cellular functions necessary for heart repair, thus playing a crucial role in cardiac regeneration. A recent study in 2020 by Beisaw et al[66], demonstrated that AP-1 regulates the expression of metabolism and cell cycle progression related genes during the process of heart regeneration as well as facilitates the expression of genes necessary for cardiomyocyte regeneration by regulating chromatin accessibility. According to Zuppo et al[89], cardiomyocyte proliferation is hampered when AP-1 expression is reduced, highlighting its crucial function in cell proliferation.
HIF-1α
The transcription factor HIF-1α is essential for coordinating cellular reactions to hypoxia or low oxygen supply[90]. Under normoxic conditions, prolyl hydroxylase domain (PHD) enzymes hydroxylate HIF-1α at particular proline residues. This post-translational alteration helps the von Hippel-Lindau E3 ubiquitin ligase complex to ubiquinate and degrade HIF-1α by proteasomal destruction[91]. Hypoxic preconditioning has been shown to increase the expression of HIF-1α through inhibition of PHDs. Similarly, ROS is also reported to stabilize HIF-1α by inhibiting PHD enzymes[92].
HIF-1α is reported to regulate angiogenesis, metabolism, and survival pathways, thus preserving cellular homeostasis in stressful situations[90]. Moeinabadi-Bidgoli et al[7] in 2021 reported that HIF-1α stimulates the production of SDF-1/CXCR4/CXCR7 signaling molecules, which play a crucial role in cell migration. Moreover, it enhances cell survival and proliferation through PI3K/Akt signaling[7]. In 2015, a study conducted by Zimna and Kurpisz[93], demonstrated that HIF-1α increases vessel formation by stimulating VEGF production. Moreover, HIF-1α at low oxygen levels, stimulates the expression of genes that produce glycolytic enzymes and pyruvate dehydrogenase, thus regulating metabolic reprogramming[94]. In 2014, a study conducted by Kuiper et al[95], demonstrated that H2O2 stabilizes HIF-1α by regulating intracellular ascorbate concentration. Similarly, another study reported that H2O2 enhances cell survival under stress conditions possibly through the stabilization of HIF-1α[96].
Preconditioning with a non-cytotoxic dose of H2O2 is reported to increase cell tolerance in stem cells. Chang et al[97] in 2008 reported that HIF-1α inhibition can reverse the H2O2 preconditioning mediated increased tolerance. Sun et al[98] in 2020 reported that HIF-1α overexpressing MSCs enhance cardiac functions and angiogenesis by increasing MSCs’ adhesion, migration, and paracrine effect. These results have suggested that HIF-1α is an important mediator in stem cell preconditioning for cardiac cell therapy. Similar results were reported by Cerrada et al[51]’s study which demonstrated that HIF-1α engineered MSCs enhance the expression of cell adhesion, migration, and paracrine factors genes. These genetically modified MSCs promote cardiac function in terms of angiogenesis, neovascularization, and heart regeneration. Moreover, expression of HIF-1α is reported to increase stem cell survival and cardiac differentiation[51].
P53
The tumor suppressor protein p53 plays a crucial role in the regulation of the cell cycle, DNA repair, apoptosis, and senescence. P53 is reported to activate NCF2/p67phox, a component of NADPH oxidase 2, which produces ROS[99]. However, it can also inhibit ROS accumulation in low-stress settings[100]. It has been established that p53 regulates several antioxidant enzymes, such as SOD2, GPx1[101], CAT[102], Grx[103], Prxs, and Sestrins[104]. Aubrey et al[105] in 2017 reported that p53 prevents apoptosis in mild stress situations by upregulation of anti-apoptotic genes like Bcl-2 and the downregulation of pro-apoptotic genes like PUMA and NOXA. This process enables cells to endure stress and bounce back[105]. In addition, p53 regulates DNA repair and antioxidant responses, which are essential for tissue regeneration and homeostasis[106]. Under stress conditions, p53 preserves energy balance by regulating metabolic processes including glycolysis and oxidative phosphorylation, which in turn improves cell survival and proliferation[107]. Moreover, p53 is reported to stimulate the production of growth factors like VEGF[108] and TGF-β[109] as well as cytokines (IL-6 and IL-8)[110] which in turn regulate inflammation, angiogenesis, and tissue regeneration. Furthermore, p53 controls the expression of cell adhesion and cytoskeletal dynamics proteins such as cadherins and integrins, Rho GTPases, and actin-binding proteins. These proteins play an important role in cell adhesion and migration during the process of tissue regeneration[111].
P53 signaling is reported to play an important role in heart development as well as essential to maintaining normal heart architecture and functions[112]. It has been reported that a low concentration of H2O2 induces the expression of p53, which in turn activates the oxidative stress combating genes such as NADPH, and glutathione (GSH) synthesis and nucleotide production genes[61]. In 2021, Goshovska et al[113] demonstrated that GSH deficiency is associated with myocardium damage during cardiac ischemia-reperfusion. Whereas, higher expression of GSH provides cardioprotection by regulating NO, AMPK, and peroxisome proliferator-activated receptor-α signaling[113]. Ye et al[59] in 2020 reported that H2O2 acts as an essential signaling molecule for zebrafish heart regeneration. Moreover, the expression of p53 isoform Δ133p53 I has been shown to increase by low-level ROS. It has been reported that Δ133p53 I, by interacting with full-length p53, promotes cell survival by enhancing the expression of antioxidant genes including GPx1a, Sestrin1, Sestrin2, aldh4, SOD1, and SOD2[59]. These p53 target genes are reported to maintain redox homeostasis within the regenerating tissue[114].
CONCLUSION
In this review, we present an overview of the protective cellular mechanisms stimulated in H2O2 preconditioned MSCs while covering the role of H2O2-activated redox sensitive TFs in heart regeneration. Cells continuously produce ROS to maintain normal physiological functions. However, increased ROS production causes molecular damage, a condition known as oxidative distress. H2O2, a ROS, acts as an intracellular messenger that regulates several physiological processes. H2O2 preconditioned MSCs have the potential to regulate biological processes related to heart regeneration such as survival, proliferation, migration, paracrine activities, and differentiation. As highlighted in this review, H2O2 might not directly regulate heart regeneration, but oxidative stress caused by a low concentration of H2O2 activates redox sensitive TFs such as Nrf2, AP-1, p53, and HIF-1α, which in turn control the intracellular signaling pathways involved in the development/regeneration of the heart. Combining H2O2 preconditioning with other induction factors may further promote stem cell-mediated heart regeneration. For this reason, it could be a major player in new therapies involving the use of stem cells for the heart diseases. In addition to heart regeneration, H2O2 preconditioned MSCs have also been found to be promising in increasing in vivo cell survival, wound healing, and regeneration of several tissues. These results indicate a broader translational perspective for H2O2 preconditioning in the field of regenerative medicine. However, in the future, it is critical to optimize H2O2 concentration and treatment time to enhance its regenerative effects and prevent oxidative damage.
Footnotes
Conflict-of-interest statement: The authors declare no conflict of interests for this article.
Provenance and peer review: Invited article; Externally peer reviewed.
Peer-review model: Single blind
Specialty type: Cardiac and cardiovascular systems
Country of origin: Pakistan
Peer-review report’s classification
Scientific Quality: Grade B, Grade C
Novelty: Grade B, Grade C
Creativity or Innovation: Grade B, Grade C
Scientific Significance: Grade B, Grade C
P-Reviewer: Shayo SC, PhD, Lecturer, Tanzania; Sun NZ, PhD, China S-Editor: Luo ML L-Editor: Wang TQ P-Editor: Wang WB
Contributor Information
Anum Siraj, Dr. Zafar H. Zaidi Center for Proteomics, University of Karachi, Karachi 75270, Sindh, Pakistan.
Kanwal Haneef, Dr. Zafar H. Zaidi Center for Proteomics, University of Karachi, Karachi 75270, Sindh, Pakistan. k.haneef@uok.edu.pk.
References
- 1.Moris D, Spartalis M, Spartalis E, Karachaliou GS, Karaolanis GI, Tsourouflis G, Tsilimigras DI, Tzatzaki E, Theocharis S. The role of reactive oxygen species in the pathophysiology of cardiovascular diseases and the clinical significance of myocardial redox. Ann Transl Med. 2017;5:326. doi: 10.21037/atm.2017.06.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Kim IC, Youn JC, Kobashigawa JA. The Past, Present and Future of Heart Transplantation. Korean Circ J. 2018;48:565–590. doi: 10.4070/kcj.2018.0189. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Clavellina D, Balkan W, Hare JM. Stem cell therapy for acute myocardial infarction: Mesenchymal Stem Cells and induced Pluripotent Stem Cells. Expert Opin Biol Ther. 2023;23:951–967. doi: 10.1080/14712598.2023.2245329. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Akbar N, Razzaq SS, Salim A, Haneef K. Mesenchymal Stem Cell-Derived Exosomes and Their MicroRNAs in Heart Repair and Regeneration. J Cardiovasc Transl Res. 2024;17:505–522. doi: 10.1007/s12265-023-10449-8. [DOI] [PubMed] [Google Scholar]
- 5.Guo Y, Yu Y, Hu S, Chen Y, Shen Z. The therapeutic potential of mesenchymal stem cells for cardiovascular diseases. Cell Death Dis. 2020;11:349. doi: 10.1038/s41419-020-2542-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Wang K, Zhang T, Dong Q, Nice EC, Huang C, Wei Y. Redox homeostasis: the linchpin in stem cell self-renewal and differentiation. Cell Death Dis. 2013;4:e537. doi: 10.1038/cddis.2013.50. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Moeinabadi-Bidgoli K, Babajani A, Yazdanpanah G, Farhadihosseinabadi B, Jamshidi E, Bahrami S, Niknejad H. Translational insights into stem cell preconditioning: From molecular mechanisms to preclinical applications. Biomed Pharmacother. 2021;142:112026. doi: 10.1016/j.biopha.2021.112026. [DOI] [PubMed] [Google Scholar]
- 8.Hu C, Li L. Preconditioning influences mesenchymal stem cell properties in vitro and in vivo. J Cell Mol Med. 2018;22:1428–1442. doi: 10.1111/jcmm.13492. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Haneef K, Salim A, Hashim Z, Ilyas A, Syed B, Ahmed A, Zarina S. Chemical Hypoxic Preconditioning Improves Survival and Proliferation of Mesenchymal Stem Cells. Appl Biochem Biotechnol. 2024;196:3719–3730. doi: 10.1007/s12010-023-04743-z. [DOI] [PubMed] [Google Scholar]
- 10.Jackson MJ, Stretton C, McArdle A. Hydrogen peroxide as a signal for skeletal muscle adaptations to exercise: What do concentrations tell us about potential mechanisms? Redox Biol. 2020;35:101484. doi: 10.1016/j.redox.2020.101484. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Hossain MA, Bhattacharjee S, Armin SM, Qian P, Xin W, Li HY, Burritt DJ, Fujita M, Tran LS. Hydrogen peroxide priming modulates abiotic oxidative stress tolerance: insights from ROS detoxification and scavenging. Front Plant Sci. 2015;6:420. doi: 10.3389/fpls.2015.00420. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Qazi RE, Khan I, Haneef K, Malick TS, Naeem N, Ahmad W, Salim A, Mohsin S. Combination of mesenchymal stem cells and three-dimensional collagen scaffold preserves ventricular remodeling in rat myocardial infarction model. World J Stem Cells. 2022;14:633–657. doi: 10.4252/wjsc.v14.i8.633. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Razzaq SS, Khan I, Naeem N, Salim A, Begum S, Haneef K. Overexpression of GATA binding protein 4 and myocyte enhancer factor 2C induces differentiation of mesenchymal stem cells into cardiac-like cells. World J Stem Cells. 2022;14:700–713. doi: 10.4252/wjsc.v14.i9.700. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res. 2008;103:1204–1219. doi: 10.1161/CIRCRESAHA.108.176826. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Sharp FR, Ran R, Lu A, Tang Y, Strauss KI, Glass T, Ardizzone T, Bernaudin M. Hypoxic preconditioning protects against ischemic brain injury. NeuroRx. 2004;1:26–35. doi: 10.1602/neurorx.1.1.26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Hao D, He C, Ma B, Lankford L, Reynaga L, Farmer DL, Guo F, Wang A. Hypoxic Preconditioning Enhances Survival and Proangiogenic Capacity of Human First Trimester Chorionic Villus-Derived Mesenchymal Stem Cells for Fetal Tissue Engineering. Stem Cells Int. 2019;2019:9695239. doi: 10.1155/2019/9695239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Chacko SM, Ahmed S, Selvendiran K, Kuppusamy ML, Khan M, Kuppusamy P. Hypoxic preconditioning induces the expression of prosurvival and proangiogenic markers in mesenchymal stem cells. Am J Physiol Cell Physiol. 2010;299:C1562–C1570. doi: 10.1152/ajpcell.00221.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Song H, Li B, Guo R, He S, Peng Z, Qu J, Zhao Y, Zhai X, Yin W, Yang K, Fan X, Zhang J, Tan J, Liu Y, Xie J, Xu J. Hypoxic preconditioned aged BMSCs accelerates MI injury repair by modulating inflammation, oxidative stress and apoptosis. Biochem Biophys Res Commun. 2022;627:45–51. doi: 10.1016/j.bbrc.2022.08.039. [DOI] [PubMed] [Google Scholar]
- 19.Hu X, Yu SP, Fraser JL, Lu Z, Ogle ME, Wang JA, Wei L. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J Thorac Cardiovasc Surg. 2008;135:799–808. doi: 10.1016/j.jtcvs.2007.07.071. [DOI] [PubMed] [Google Scholar]
- 20.Zhao Y, Xiong W, Li C, Zhao R, Lu H, Song S, Zhou Y, Hu Y, Shi B, Ge J. Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets. Signal Transduct Target Ther. 2023;8:431. doi: 10.1038/s41392-023-01652-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Zhuo H, Chen Y, Zhao G. Advances in application of hypoxia-preconditioned mesenchymal stem cell-derived exosomes. Front Cell Dev Biol. 2024;12:1446050. doi: 10.3389/fcell.2024.1446050. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Volz M, Wyse-Sookoo KR, Travascio F, Huang CY, Best TM. Mechanobiological Approaches for Stimulating Chondrogenesis of Stem Cells. Stem Cells Dev. 2022;31:460–487. doi: 10.1089/scd.2022.0049. [DOI] [PubMed] [Google Scholar]
- 23.Haneef K, Lila N, Benadda S, Legrand F, Carpentier A, Chachques JC. Development of bioartificial myocardium by electrostimulation of 3D collagen scaffolds seeded with stem cells. Heart Int. 2012;7:e14. doi: 10.4081/hi.2012.e14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Huang Y, Qian JY, Cheng H, Li XM. Effects of shear stress on differentiation of stem cells into endothelial cells. World J Stem Cells. 2021;13:894–913. doi: 10.4252/wjsc.v13.i7.894. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Correa-Meyer E, Pesce L, Guerrero C, Sznajder JI. Cyclic stretch activates ERK1/2 via G proteins and EGFR in alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2002;282:L883–L891. doi: 10.1152/ajplung.00203.2001. [DOI] [PubMed] [Google Scholar]
- 26.Islam R, Hong Z. YAP/TAZ as mechanobiological signaling pathway in cardiovascular physiological regulation and pathogenesis. Mechanobiol Med. 2024;2:100085. doi: 10.1016/j.mbm.2024.100085. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Raman N, Imran SAM, Ahmad Amin Noordin KB, Wan Kamarul Zaman WS, Nordin F. Mechanotransduction of mesenchymal stem cells (MSCs) during cardiomyocytes differentiation. Heliyon. 2022;8:e11624. doi: 10.1016/j.heliyon.2022.e11624. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Ullah M, Liu DD, Thakor AS. Mesenchymal Stromal Cell Homing: Mechanisms and Strategies for Improvement. iScience. 2019;15:421–438. doi: 10.1016/j.isci.2019.05.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Matta A, Nader V, Lebrin M, Gross F, Prats AC, Cussac D, Galinier M, Roncalli J. Pre-Conditioning Methods and Novel Approaches with Mesenchymal Stem Cells Therapy in Cardiovascular Disease. Cells. 2022;11:1620. doi: 10.3390/cells11101620. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Pasha Z, Wang Y, Sheikh R, Zhang D, Zhao T, Ashraf M. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc Res. 2008;77:134–142. doi: 10.1093/cvr/cvm025. [DOI] [PubMed] [Google Scholar]
- 31.Lin H, Ling Y, Pan J, Gong H. Therapeutic effects of erythropoietin expressed in mesenchymal stem cells for dilated cardiomyopathy in rat. Biochem Biophys Res Commun. 2019;517:575–580. doi: 10.1016/j.bbrc.2019.07.053. [DOI] [PubMed] [Google Scholar]
- 32.Kang M, Huang CC, Gajendrareddy P, Lu Y, Shirazi S, Ravindran S, Cooper LF. Extracellular Vesicles From TNFα Preconditioned MSCs: Effects on Immunomodulation and Bone Regeneration. Front Immunol. 2022;13:878194. doi: 10.3389/fimmu.2022.878194. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Huang X, Liang X, Han Q, Shen Y, Chen J, Li Z, Qiu J, Gao X, Hong Y, Lin F, Li W, Li X, Zhang Y. Pretreatment with growth differentiation factor 15 augments cardioprotection by mesenchymal stem cells in myocardial infarction by improving their survival. Stem Cell Res Ther. 2024;15:412. doi: 10.1186/s13287-024-04030-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Nouri F, Nematollahi-Mahani SN, Sharifi AM. Preconditioning of Mesenchymal Stem Cells with Non-Toxic Concentration of Hydrogen Peroxide Against Oxidative Stress Induced Cell Death: The Role of Hypoxia-Inducible Factor-1. Adv Pharm Bull. 2019;9:76–83. doi: 10.15171/apb.2019.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Guo L, Du J, Yuan DF, Zhang Y, Zhang S, Zhang HC, Mi JW, Ning YL, Chen MJ, Wen DL, Sun JH, Liu D, Zeng L, Zhang A, Jiang J, Huang H. Optimal H(2)O(2) preconditioning to improve bone marrow mesenchymal stem cells' engraftment in wound healing. Stem Cell Res Ther. 2020;11:434. doi: 10.1186/s13287-020-01910-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Jalali L, Allahveisie A, Rezaei S, Ravanyar L, Kiasatfar J, Rezaie MJ, Raoofi A. Effect of preconditioning of human umbilical cord mesenchymal stem cells with hydrogen peroxide on the therapeutic potential of MSCs in the cyclophosphamide -induced premature ovarian failure mice model. Taiwan J Obstet Gynecol. 2023;62:667–676. doi: 10.1016/j.tjog.2023.07.007. [DOI] [PubMed] [Google Scholar]
- 37.Garrido-Pascual P, Alonso-Varona A, Castro B, Burón M, Palomares T. H(2)O(2)-preconditioned human adipose-derived stem cells (HC016) increase their resistance to oxidative stress by overexpressing Nrf2 and bioenergetic adaptation. Stem Cell Res Ther. 2020;11:335. doi: 10.1186/s13287-020-01851-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Burón M, Palomares T, Garrido-Pascual P, Herrero de la Parte B, García-Alonso I, Alonso-Varona A. Conditioned Medium from H(2)O(2)-Preconditioned Human Adipose-Derived Stem Cells Ameliorates UVB-Induced Damage to Human Dermal Fibroblasts. Antioxidants (Basel) 2022;11:2011. doi: 10.3390/antiox11102011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Mahmoudi T, Abdolmohammadi K, Bashiri H, Mohammadi M, Rezaie MJ, Fathi F, Fakhari S, Rezaee MA, Jalili A, Rahmani MR, Tayebi L. Hydrogen Peroxide Preconditioning Promotes Protective Effects of Umbilical Cord Vein Mesenchymal Stem Cells in Experimental Pulmonary Fibrosis. Adv Pharm Bull. 2020;10:72–80. doi: 10.15171/apb.2020.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Li D, Xu Y, Gao CY, Zhai YP. Adaptive protection against damage of preconditioning human umbilical cord-derived mesenchymal stem cells with hydrogen peroxide. Genet Mol Res. 2014;13:7304–7317. doi: 10.4238/2014.February.21.9. [DOI] [PubMed] [Google Scholar]
- 41.Khatlani T, Algudiri D, Alenzi R, Al Subayyil AM, Abomaray FM, Bahattab E, AlAskar AS, Kalionis B, El-Muzaini MF, Abumaree MH. Preconditioning by Hydrogen Peroxide Enhances Multiple Properties of Human Decidua Basalis Mesenchymal Stem/Multipotent Stromal Cells. Stem Cells Int. 2018;2018:6480793. doi: 10.1155/2018/6480793. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Boopathy AV, Pendergrass KD, Che PL, Yoon YS, Davis ME. Oxidative stress-induced Notch1 signaling promotes cardiogenic gene expression in mesenchymal stem cells. Stem Cell Res Ther. 2013;4:43. doi: 10.1186/scrt190. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.O'Leary MF. Mesenchymal stem cell pre-treatment with cytokines and hydrogen peroxide modifies their adhesion to cardiac endothelium and murine heart sections AND A preliminary study of the molecular regulation of placental growth factor and vascular endothelial growth factor in murine preadipocytes. College of Medical and Dental Sciences University of Birmingham. 2014. [Google Scholar]
- 44.Angeloni C, Motori E, Fabbri D, Malaguti M, Leoncini E, Lorenzini A, Hrelia S. H2O2 preconditioning modulates phase II enzymes through p38 MAPK and PI3K/Akt activation. Am J Physiol Heart Circ Physiol. 2011;300:H2196–H2205. doi: 10.1152/ajpheart.00934.2010. [DOI] [PubMed] [Google Scholar]
- 45.Garrido Pascual P, Elucidation of the molecular and bionergetic mechanisms underlying the resistance to oxidatives stress and the pro-recovery effect of H2O2- preconditioned adipose-derived stem cells. Universidad del País Vasco-Euskal Herriko Unibertsitatea. 2020. [Google Scholar]
- 46.Sadidi M, Lentz SI, Feldman EL. Hydrogen peroxide-induced Akt phosphorylation regulates Bax activation. Biochimie. 2009;91:577–585. doi: 10.1016/j.biochi.2009.01.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Vasanthan J, Gurusamy N, Rajasingh S, Sigamani V, Kirankumar S, Thomas EL, Rajasingh J. Role of Human Mesenchymal Stem Cells in Regenerative Therapy. Cells. 2020;10:54. doi: 10.3390/cells10010054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Zhang J, Chen GH, Wang YW, Zhao J, Duan HF, Liao LM, Zhang XZ, Chen YD, Chen H. Hydrogen peroxide preconditioning enhances the therapeutic efficacy of Wharton's Jelly mesenchymal stem cells after myocardial infarction. Chin Med J (Engl) 2012;125:3472–3478. [PubMed] [Google Scholar]
- 49.Castro B, Martinez-Redondo D, Gartzia I, Alonso-Varona A, Garrido P, Palomares T. Cryopreserved H(2) O(2) -preconditioned human adipose-derived stem cells exhibit fast post-thaw recovery and enhanced bioactivity against oxidative stress. J Tissue Eng Regen Med. 2019;13:328–341. doi: 10.1002/term.2797. [DOI] [PubMed] [Google Scholar]
- 50.Han P, Zhou XH, Chang N, Xiao CL, Yan S, Ren H, Yang XZ, Zhang ML, Wu Q, Tang B, Diao JP, Zhu X, Zhang C, Li CY, Cheng H, Xiong JW. Hydrogen peroxide primes heart regeneration with a derepression mechanism. Cell Res. 2014;24:1091–1107. doi: 10.1038/cr.2014.108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Cerrada I, Ruiz-Saurí A, Carrero R, Trigueros C, Dorronsoro A, Sanchez-Puelles JM, Diez-Juan A, Montero JA, Sepúlveda P. Hypoxia-inducible factor 1 alpha contributes to cardiac healing in mesenchymal stem cells-mediated cardiac repair. Stem Cells Dev. 2013;22:501–511. doi: 10.1089/scd.2012.0340. [DOI] [PubMed] [Google Scholar]
- 52.Pankajakshan D, Agrawal DK. Mesenchymal Stem Cell Paracrine Factors in Vascular Repair and Regeneration. J Biomed Technol Res. 2014;1 doi: 10.19104/jbtr.2014.107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Dave A, Kar S, Banerjee ER. Effect of CoCl2 or H2O2 pre-conditioned mesenchymal stem cells in a mouse model of pulmonary fibrosis. Biomed Res Ther. 2018;5:2208–2222. [Google Scholar]
- 54.Pendergrass KD, Boopathy AV, Seshadri G, Maiellaro-Rafferty K, Che PL, Brown ME, Davis ME. Acute preconditioning of cardiac progenitor cells with hydrogen peroxide enhances angiogenic pathways following ischemia-reperfusion injury. Stem Cells Dev. 2013;22:2414–2424. doi: 10.1089/scd.2012.0673. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Li Q, Wang Y, Deng Z. Pre-conditioned mesenchymal stem cells: a better way for cell-based therapy. Stem Cell Res Ther. 2013;4:63. doi: 10.1186/scrt213. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Li Y, Hiroi Y, Liao JK. Notch signaling as an important mediator of cardiac repair and regeneration after myocardial infarction. Trends Cardiovasc Med. 2010;20:228–231. doi: 10.1016/j.tcm.2011.11.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Liang J, Wu M, Chen C, Mai M, Huang J, Zhu P. Roles of Reactive Oxygen Species in Cardiac Differentiation, Reprogramming, and Regenerative Therapies. Oxid Med Cell Longev. 2020;2020:2102841. doi: 10.1155/2020/2102841. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Dreger H, Westphal K, Weller A, Baumann G, Stangl V, Meiners S, Stangl K. Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for proteasome inhibitor-mediated cardioprotection. Cardiovasc Res. 2009;83:354–361. doi: 10.1093/cvr/cvp107. [DOI] [PubMed] [Google Scholar]
- 59.Ye S, Zhao T, Zhang W, Tang Z, Gao C, Ma Z, Xiong JW, Peng J, Tan WQ, Chen J. p53 isoform Δ113p53 promotes zebrafish heart regeneration by maintaining redox homeostasis. Cell Death Dis. 2020;11:568. doi: 10.1038/s41419-020-02781-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Qin F, Siwik DA, Lancel S, Zhang J, Kuster GM, Luptak I, Wang L, Tong X, Kang YJ, Cohen RA, Colucci WS. Hydrogen peroxide-mediated SERCA cysteine 674 oxidation contributes to impaired cardiac myocyte relaxation in senescent mouse heart. J Am Heart Assoc. 2013;2:e000184. doi: 10.1161/JAHA.113.000184. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Sartoretto JL, Kalwa H, Pluth MD, Lippard SJ, Michel T. Hydrogen peroxide differentially modulates cardiac myocyte nitric oxide synthesis. Proc Natl Acad Sci U S A. 2011;108:15792–15797. doi: 10.1073/pnas.1111331108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Bardaweel SK, Gul M, Alzweiri M, Ishaqat A, ALSalamat HA, Bashatwah RM. Reactive Oxygen Species: the Dual Role in Physiological and Pathological Conditions of the Human Body. Eurasian J Med. 2018;50:193–201. doi: 10.5152/eurasianjmed.2018.17397. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Andrés CMC, Pérez de la Lastra JM, Juan CA, Plou FJ, Pérez-lebeña E. Chemistry of Hydrogen Peroxide Formation and Elimination in Mammalian Cells, and Its Role in Various Pathologies. Stresses. 2022;2:256–274. [Google Scholar]
- 64.Averill-Bates D. Reactive oxygen species and cell signaling. Review. Biochim Biophys Acta Mol Cell Res. 2024;1871:119573. doi: 10.1016/j.bbamcr.2023.119573. [DOI] [PubMed] [Google Scholar]
- 65.Jose E, March-Steinman W, Wilson BA, Shanks L, Parkinson C, Alvarado-Cruz I, Sweasy JB, Paek AL. Temporal coordination of the transcription factor response to H(2)O(2) stress. Nat Commun. 2024;15:3440. doi: 10.1038/s41467-024-47837-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Beisaw A, Kuenne C, Guenther S, Dallmann J, Wu CC, Bentsen M, Looso M, Stainier DYR. AP-1 Contributes to Chromatin Accessibility to Promote Sarcomere Disassembly and Cardiomyocyte Protrusion During Zebrafish Heart Regeneration. Circ Res. 2020;126:1760–1778. doi: 10.1161/CIRCRESAHA.119.316167. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Hou J, Wang L, Long H, Wu H, Wu Q, Zhong T, Chen X, Zhou C, Guo T, Wang T. Hypoxia preconditioning promotes cardiac stem cell survival and cardiogenic differentiation in vitro involving activation of the HIF-1α/apelin/APJ axis. Stem Cell Res Ther. 2017;8:215. doi: 10.1186/s13287-017-0673-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Hammad M, Raftari M, Cesário R, Salma R, Godoy P, Emami SN, Haghdoost S. Roles of Oxidative Stress and Nrf2 Signaling in Pathogenic and Non-Pathogenic Cells: A Possible General Mechanism of Resistance to Therapy. Antioxidants (Basel) 2023;12:1371. doi: 10.3390/antiox12071371. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Ma K, Miao L, Li B, Yu W, Liu F, Liu K, Li Y, Huang C, Yang Z. Mechanism of action of Nrf2 and its related natural regulators in rheumatoid arthritis. J Orthop Surg Res. 2024;19:759. doi: 10.1186/s13018-024-05221-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Dai X, Yan X, Wintergerst KA, Cai L, Keller BB, Tan Y. Nrf2: Redox and Metabolic Regulator of Stem Cell State and Function. Trends Mol Med. 2020;26:185–200. doi: 10.1016/j.molmed.2019.09.007. [DOI] [PubMed] [Google Scholar]
- 71.Márton M, Tihanyi N, Gyulavári P, Bánhegyi G, Kapuy O. NRF2-regulated cell cycle arrest at early stage of oxidative stress response mechanism. PLoS One. 2018;13:e0207949. doi: 10.1371/journal.pone.0207949. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Park PSU, Mun SH, Zeng SL, Kim H, Bae S, Park-Min KH. NRF2 Is an Upstream Regulator of MYC-Mediated Osteoclastogenesis and Pathological Bone Erosion. Cells. 2020;9:2133. doi: 10.3390/cells9092133. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Ishii T, Warabi E, Mann GE. Mechanisms underlying Nrf2 nuclear translocation by non-lethal levels of hydrogen peroxide: p38 MAPK-dependent neutral sphingomyelinase2 membrane trafficking and ceramide/PKCζ/CK2 signaling. Free Radic Biol Med. 2022;191:191–202. doi: 10.1016/j.freeradbiomed.2022.08.036. [DOI] [PubMed] [Google Scholar]
- 74.Covas G, Marinho HS, Cyrne L, Antunes F. Activation of Nrf2 by H2O2: de novo synthesis versus nuclear translocation. Methods Enzymol. 2013;528:157–171. doi: 10.1016/B978-0-12-405881-1.00009-4. [DOI] [PubMed] [Google Scholar]
- 75.Yang X, Fang Y, Hou J, Wang X, Li J, Li S, Zheng X, Liu Y, Zhang Z. The heart as a target for deltamethrin toxicity: Inhibition of Nrf2/HO-1 pathway induces oxidative stress and results in inflammation and apoptosis. Chemosphere. 2022;300:134479. doi: 10.1016/j.chemosphere.2022.134479. [DOI] [PubMed] [Google Scholar]
- 76.Zoccarato A, Smyrnias I, Reumiller CM, Hafstad AD, Chong M, Richards DA, Santos CXC, Visnagri A, Verma S, Bromage DI, Zhang M, Zhang X, Sawyer G, Thompson R, Shah AM. NRF2 activation in the heart induces glucose metabolic reprogramming and reduces cardiac dysfunction via upregulation of the pentose phosphate pathway. Cardiovasc Res. 2025;121:339–352. doi: 10.1093/cvr/cvae250. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Hong Y, Boiti A, Vallone D, Foulkes NS. Reactive Oxygen Species Signaling and Oxidative Stress: Transcriptional Regulation and Evolution. Antioxidants (Basel) 2024;13:312. doi: 10.3390/antiox13030312. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Karin M, Liu Zg, Zandi E. AP-1 function and regulation. Curr Opin Cell Biol. 1997;9:240–246. doi: 10.1016/s0955-0674(97)80068-3. [DOI] [PubMed] [Google Scholar]
- 79.Pinkus R, Weiner LM, Daniel V. Role of oxidants and antioxidants in the induction of AP-1, NF-kappaB, and glutathione S-transferase gene expression. J Biol Chem. 1996;271:13422–13429. doi: 10.1074/jbc.271.23.13422. [DOI] [PubMed] [Google Scholar]
- 80.Eferl R, Wagner EF. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer. 2003;3:859–868. doi: 10.1038/nrc1209. [DOI] [PubMed] [Google Scholar]
- 81.Windak R, Müller J, Felley A, Akhmedov A, Wagner EF, Pedrazzini T, Sumara G, Ricci R. The AP-1 transcription factor c-Jun prevents stress-imposed maladaptive remodeling of the heart. PLoS One. 2013;8:e73294. doi: 10.1371/journal.pone.0073294. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Eriksson M, Leppä S. Mitogen-activated protein kinases and activator protein 1 are required for proliferation and cardiomyocyte differentiation of P19 embryonal carcinoma cells. J Biol Chem. 2002;277:15992–16001. doi: 10.1074/jbc.M107340200. [DOI] [PubMed] [Google Scholar]
- 83.Murray TV, Smyrnias I, Shah AM, Brewer AC. NADPH oxidase 4 regulates cardiomyocyte differentiation via redox activation of c-Jun protein and the cis-regulation of GATA-4 gene transcription. J Biol Chem. 2013;288:15745–15759. doi: 10.1074/jbc.M112.439844. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.López-Camarillo C, Ocampo EA, Casamichana ML, Pérez-Plasencia C, Alvarez-Sánchez E, Marchat LA. Protein kinases and transcription factors activation in response to UV-radiation of skin: implications for carcinogenesis. Int J Mol Sci. 2012;13:142–172. doi: 10.3390/ijms13010142. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Kikuta K, Masamune A, Satoh M, Suzuki N, Satoh K, Shimosegawa T. Hydrogen peroxide activates activator protein-1 and mitogen-activated protein kinases in pancreatic stellate cells. Mol Cell Biochem. 2006;291:11–20. doi: 10.1007/s11010-006-9189-4. [DOI] [PubMed] [Google Scholar]
- 86.Xu Y, Bradham C, Brenner DA, Czaja MJ. Hydrogen peroxide-induced liver cell necrosis is dependent on AP-1 activation. Am J Physiol. 1997;273:G795–G803. doi: 10.1152/ajpgi.1997.273.4.G795. [DOI] [PubMed] [Google Scholar]
- 87.Jiang T, Qu JJ, Nishinaka T, Zhang N. Transcription factor AP-1 regulates TGF-beta(1)-induced expression of aldose reductase in cultured human mesangial cells. Nephrology (Carlton) 2008;13:212–217. doi: 10.1111/j.1440-1797.2007.00913.x. [DOI] [PubMed] [Google Scholar]
- 88.Guo ZY, Hao XH, Tan FF, Pei X, Shang LM, Jiang XL, Yang F. The elements of human cyclin D1 promoter and regulation involved. Clin Epigenetics. 2011;2:63–76. doi: 10.1007/s13148-010-0018-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Zuppo DA, Missinato MA, Santana-Santos L, Li G, Benos PV, Tsang M. Foxm1 regulates cardiomyocyte proliferation in adult zebrafish after cardiac injury. Development. 2023;150:dev201163. doi: 10.1242/dev.201163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Basheeruddin M, Qausain S. Hypoxia-Inducible Factor 1-Alpha (HIF-1α): An Essential Regulator in Cellular Metabolic Control. Cureus. 2024;16:e63852. doi: 10.7759/cureus.63852. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Yang M, Su H, Soga T, Kranc KR, Pollard PJ. Prolyl hydroxylase domain enzymes: important regulators of cancer metabolism. Hypoxia (Auckl) 2014;2:127–142. doi: 10.2147/HP.S47968. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Bae T, Hallis SP, Kwak MK. Hypoxia, oxidative stress, and the interplay of HIFs and NRF2 signaling in cancer. Exp Mol Med. 2024;56:501–514. doi: 10.1038/s12276-024-01180-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Zimna A, Kurpisz M. Hypoxia-Inducible Factor-1 in Physiological and Pathophysiological Angiogenesis: Applications and Therapies. Biomed Res Int. 2015;2015:549412. doi: 10.1155/2015/549412. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Zhang J, Gao P, Chang WR, Song JY, An FY, Wang YJ, Xiao ZP, Jin H, Zhang XH, Yan CL. The role of HIF-1α in hypoxic metabolic reprogramming in osteoarthritis. Pharmacol Res. 2025;213:107649. doi: 10.1016/j.phrs.2025.107649. [DOI] [PubMed] [Google Scholar]
- 95.Kuiper C, Dachs GU, Currie MJ, Vissers MC. Intracellular ascorbate enhances hypoxia-inducible factor (HIF)-hydroxylase activity and preferentially suppresses the HIF-1 transcriptional response. Free Radic Biol Med. 2014;69:308–317. doi: 10.1016/j.freeradbiomed.2014.01.033. [DOI] [PubMed] [Google Scholar]
- 96.Xie M, Roy R. Increased levels of hydrogen peroxide induce a HIF-1-dependent modification of lipid metabolism in AMPK compromised C. elegans dauer larvae. Cell Metab. 2012;16:322–335. doi: 10.1016/j.cmet.2012.07.016. [DOI] [PubMed] [Google Scholar]
- 97.Chang S, Jiang X, Zhao C, Lee C, Ferriero DM. Exogenous low dose hydrogen peroxide increases hypoxia-inducible factor-1alpha protein expression and induces preconditioning protection against ischemia in primary cortical neurons. Neurosci Lett. 2008;441:134–138. doi: 10.1016/j.neulet.2008.06.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Sun J, Shen H, Shao L, Teng X, Chen Y, Liu X, Yang Z, Shen Z. HIF-1α overexpression in mesenchymal stem cell-derived exosomes mediates cardioprotection in myocardial infarction by enhanced angiogenesis. Stem Cell Res Ther. 2020;11:373. doi: 10.1186/s13287-020-01881-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.He Z, Simon HU. A novel link between p53 and ROS. Cell Cycle. 2013;12:201–202. doi: 10.4161/cc.23418. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Sablina AA, Budanov AV, Ilyinskaya GV, Agapova LS, Kravchenko JE, Chumakov PM. The antioxidant function of the p53 tumor suppressor. Nat Med. 2005;11:1306–1313. doi: 10.1038/nm1320. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Hussain SP, Amstad P, He P, Robles A, Lupold S, Kaneko I, Ichimiya M, Sengupta S, Mechanic L, Okamura S, Hofseth LJ, Moake M, Nagashima M, Forrester KS, Harris CC. p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. Cancer Res. 2004;64:2350–2356. doi: 10.1158/0008-5472.can-2287-2. [DOI] [PubMed] [Google Scholar]
- 102.Kang MY, Kim HB, Piao C, Lee KH, Hyun JW, Chang IY, You HJ. The critical role of catalase in prooxidant and antioxidant function of p53. Cell Death Differ. 2013;20:117–129. doi: 10.1038/cdd.2012.102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103.Ogata FT, Branco V, Vale FF, Coppo L. Glutaredoxin: Discovery, redox defense and much more. Redox Biol. 2021;43:101975. doi: 10.1016/j.redox.2021.101975. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.Budanov AV, Sablina AA, Feinstein E, Koonin EV, Chumakov PM. Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science. 2004;304:596–600. doi: 10.1126/science.1095569. [DOI] [PubMed] [Google Scholar]
- 105.Aubrey BJ, Kelly GL, Janic A, Herold MJ, Strasser A. How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? Cell Death Differ. 2018;25:104–113. doi: 10.1038/cdd.2017.169. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 106.Pitolli C, Wang Y, Candi E, Shi Y, Melino G, Amelio I. p53-Mediated Tumor Suppression: DNA-Damage Response and Alternative Mechanisms. Cancers (Basel) 2019;11:1983. doi: 10.3390/cancers11121983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107.Zhang XD, Qin ZH, Wang J. The role of p53 in cell metabolism. Acta Pharmacol Sin. 2010;31:1208–1212. doi: 10.1038/aps.2010.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108.Yuan A, Yu CJ, Luh KT, Kuo SH, Lee YC, Yang PC. Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancer. J Clin Oncol. 2002;20:900–910. doi: 10.1200/JCO.2002.20.4.900. [DOI] [PubMed] [Google Scholar]
- 109.Elston R, Inman GJ. Crosstalk between p53 and TGF-β Signalling. J Signal Transduct. 2012;2012:294097. doi: 10.1155/2012/294097. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 110.Lowe JM, Menendez D, Bushel PR, Shatz M, Kirk EL, Troester MA, Garantziotis S, Fessler MB, Resnick MA. p53 and NF-κB coregulate proinflammatory gene responses in human macrophages. Cancer Res. 2014;74:2182–2192. doi: 10.1158/0008-5472.CAN-13-1070. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111.Araki K, Ebata T, Guo AK, Tobiume K, Wolf SJ, Kawauchi K. p53 regulates cytoskeleton remodeling to suppress tumor progression. Cell Mol Life Sci. 2015;72:4077–4094. doi: 10.1007/s00018-015-1989-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112.Wang H, Yu W, Wang Y, Wu R, Dai Y, Deng Y, Wang S, Yuan J, Tan R. p53 contributes to cardiovascular diseases via mitochondria dysfunction: A new paradigm. Free Radic Biol Med. 2023;208:846–858. doi: 10.1016/j.freeradbiomed.2023.09.036. [DOI] [PubMed] [Google Scholar]
- 113.Goshovska YV, Fedichkina RA, Balatskyi VV, Piven OO, Dobrzyn P, Sagach VF. Induction of Glutathione Synthesis Provides Cardioprotection Regulating NO, AMPK and PPARa Signaling in Ischemic Rat Hearts. Life (Basel) 2021;11:631. doi: 10.3390/life11070631. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 114.Humpton TJ, Hall H, Kiourtis C, Nixon C, Clark W, Hedley A, Shaw R, Bird TG, Blyth K, Vousden KH. p53-mediated redox control promotes liver regeneration and maintains liver function in response to CCl(4) Cell Death Differ. 2022;29:514–526. doi: 10.1038/s41418-021-00871-3. [DOI] [PMC free article] [PubMed] [Google Scholar]

